Administration of T Lymphocytes for Prevention of Relapse of Lymphomas (Q65465834)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of T Lymphocytes for Prevention of Relapse of Lymphomas |
clinical trial |
Statements
Phase I Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Prevention of Relapse of CD30+ Lymphomas After High Dose Therapy and Autologous Stem Transplantation (ATLAS) (English)
0 references
15 July 2016
0 references
September 2019
0 references
18
0 references
3 year
0 references